Novartis' Fabhalta showed significant efficacy and safety in a Phase 3 IgA nephropathy study, supporting regulatory filings ...
The Mid Yorkshire Teaching NHS Trust has become the first NHS organisation in the country to pilot the Sysmex PA-100.
You probably aren't drinking enough water, and Kohler's newest device tells you so -- from your toilet. Kohler unveiled Dekoda, a sensor that attaches to a toilet to monitor hydration, gut health, ...